4//SEC Filing
AKESIS PHARMACEUTICALS, INC. 4
Accession 0001116679-08-001534
CIK 0001042420operating
Filed
Jun 19, 8:00 PM ET
Accepted
Jun 20, 5:18 PM ET
Size
6.0 KB
Accession
0001116679-08-001534
Insider Transaction Report
Form 4
Hendrick John T
Chief Financial Officer
Transactions
- Award
Options to Purchase Common Stock
2008-06-13+125,000→ 375,000 totalExercise: $0.66Exp: 2018-06-13→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The options vest in equal monthly installments over a three-year period commencing on the date of grant and subject to the continued status of reporting person as a service provider to the issuer on each vesting date.
- [F2]Consists of 375,000 options to purchase Common Stock.
Documents
Issuer
AKESIS PHARMACEUTICALS, INC.
CIK 0001042420
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001042420
Filing Metadata
- Form type
- 4
- Filed
- Jun 19, 8:00 PM ET
- Accepted
- Jun 20, 5:18 PM ET
- Size
- 6.0 KB